Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1997 May;6(5):929–955. doi: 10.1002/pro.5560060501

Interleukin-6: structure-function relationships.

R J Simpson 1, A Hammacher 1, D K Smith 1, J M Matthews 1, L D Ward 1
PMCID: PMC2143693  PMID: 9144766

Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities and its potent ability to induce the acute phase response. Overexpression of IL-6 has been implicated in the pathology of a number of diseases including multiple myeloma, rheumatoid arthritis, Castleman's disease, psoriasis, and post-menopausal osteoporosis. Hence, selective antagonists of IL-6 action may offer therapeutic benefits. IL-6 is a member of the family of cytokines that includes interleukin-11, leukemia inhibitory factor, oncostatin M, cardiotrophin-1, and ciliary neurotrophic factor. Like the other members of this family, IL-6 induces growth or differentiation via a receptor-system that involves a specific receptor and the use of a shared signaling subunit, gp130. Identification of the regions of IL-6 that are involved in the interactions with the IL-6 receptor, and gp130 is an important first step in the rational manipulation of the effects of this cytokine for therapeutic benefit. In this review, we focus on the sites on IL-6 which interact with its low-affinity specific receptor, the IL-6 receptor, and the high-affinity converter gp130. A tentative model for the IL-6 hexameric receptor ligand complex is presented and discussed with respect to the mechanism of action of the other members of the IL-6 family of cytokines.

Full Text

The Full Text of this article is available as a PDF (14.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi: 10.1016/s0065-2776(08)60532-5. [DOI] [PubMed] [Google Scholar]
  2. Andrews A. E., Barcham G. J., Ashman K., Meeusen E. N., Brandon M. R., Nash A. D. Molecular cloning and characterization of a ruminant interleukin-6 cDNA. Immunol Cell Biol. 1993 Aug;71(Pt 4):341–348. doi: 10.1038/icb.1993.39. [DOI] [PubMed] [Google Scholar]
  3. Baumann H., Symes A. J., Comeau M. R., Morella K. K., Wang Y., Friend D., Ziegler S. F., Fink J. S., Gearing D. P. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol Cell Biol. 1994 Jan;14(1):138–146. doi: 10.1128/mcb.14.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baumann H., Wang Y., Morella K. K., Lai C. F., Dams H., Hilton D. J., Hawley R. G., Mackiewicz A. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol. 1996 Jul 1;157(1):284–290. [PubMed] [Google Scholar]
  5. Baumann M., Baumann H., Fey G. H. Molecular cloning, characterization and functional expression of the rat liver interleukin 6 receptor. J Biol Chem. 1990 Nov 15;265(32):19853–19862. [PubMed] [Google Scholar]
  6. Bazan J. F. Haemopoietic receptors and helical cytokines. Immunol Today. 1990 Oct;11(10):350–354. doi: 10.1016/0167-5699(90)90139-z. [DOI] [PubMed] [Google Scholar]
  7. Bazan J. F. Neuropoietic cytokines in the hematopoietic fold. Neuron. 1991 Aug;7(2):197–208. doi: 10.1016/0896-6273(91)90258-2. [DOI] [PubMed] [Google Scholar]
  8. Bazan J. F. Shared architecture of hormone binding domains in type I and II interferon receptors. Cell. 1990 Jun 1;61(5):753–754. doi: 10.1016/0092-8674(90)90182-e. [DOI] [PubMed] [Google Scholar]
  9. Bork P., Holm L., Sander C. The immunoglobulin fold. Structural classification, sequence patterns and common core. J Mol Biol. 1994 Sep 30;242(4):309–320. doi: 10.1006/jmbi.1994.1582. [DOI] [PubMed] [Google Scholar]
  10. Boulay J. L., Paul W. E. Hematopoietin sub-family classification based on size, gene organization and sequence homology. Curr Biol. 1993 Sep 1;3(9):573–581. doi: 10.1016/0960-9822(93)90002-6. [DOI] [PubMed] [Google Scholar]
  11. Bradley W. G., Gibbs C., Kraus L., Good R. A., Day N. K. Molecular cloning and characterization of a cDNA encoding feline interleukin-6. Proc Soc Exp Biol Med. 1993 Dec;204(3):301–305. doi: 10.3181/00379727-204-43666. [DOI] [PubMed] [Google Scholar]
  12. Brakenhoff J. P., Hart M., Aarden L. A. Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28. J Immunol. 1989 Aug 15;143(4):1175–1182. [PubMed] [Google Scholar]
  13. Brakenhoff J. P., Hart M., De Groot E. R., Di Padova F., Aarden L. A. Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. J Immunol. 1990 Jul 15;145(2):561–568. [PubMed] [Google Scholar]
  14. Brakenhoff J. P., de Groot E. R., Evers R. F., Pannekoek H., Aarden L. A. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol. 1987 Dec 15;139(12):4116–4121. [PubMed] [Google Scholar]
  15. Brandhuber B. J., Boone T., Kenney W. C., McKay D. B. Three-dimensional structure of interleukin-2. Science. 1987 Dec 18;238(4834):1707–1709. doi: 10.1126/science.3500515. [DOI] [PubMed] [Google Scholar]
  16. Breen E. C., Rezai A. R., Nakajima K., Beall G. N., Mitsuyasu R. T., Hirano T., Kishimoto T., Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol. 1990 Jan 15;144(2):480–484. [PubMed] [Google Scholar]
  17. Brems D. N., Brown P. L., Becker G. W. Equilibrium denaturation of human growth hormone and its cysteine-modified forms. J Biol Chem. 1990 Apr 5;265(10):5504–5511. [PubMed] [Google Scholar]
  18. Breton J., La Fiura A., Bertolero F., Orsini G., Valsasina B., Ziliotto R., De Filippis V., Polverino de Laureto P., Fontana A. Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond. Eur J Biochem. 1995 Jan 15;227(1-2):573–581. doi: 10.1111/j.1432-1033.1995.tb20427.x. [DOI] [PubMed] [Google Scholar]
  19. Brosh N., Sternberg D., Honigwachs-Sha'anani J., Lee B. C., Shav-Tal Y., Tzehoval E., Shulman L. M., Toledo J., Hacham Y., Carmi P. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11. Identification as a stroma-derived activin A. J Biol Chem. 1995 Dec 8;270(49):29594–29600. doi: 10.1074/jbc.270.49.29594. [DOI] [PubMed] [Google Scholar]
  20. Chevalier S., Fourcin M., Robledo O., Wijdenes J., Pouplard-Barthelaix A., Gascan H. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. J Biol Chem. 1996 Jun 21;271(25):14764–14772. doi: 10.1074/jbc.271.25.14764. [DOI] [PubMed] [Google Scholar]
  21. Chérel M., Sorel M., Lebeau B., Dubois S., Moreau J. F., Bataille R., Minvielle S., Jacques Y. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood. 1995 Oct 1;86(7):2534–2540. [PubMed] [Google Scholar]
  22. Ciapponi L., Graziani R., Paonessa G., Lahm A., Ciliberto G., Savino R. Definition of a composite binding site for gp130 in human interleukin-6. J Biol Chem. 1995 Dec 29;270(52):31249–31254. doi: 10.1074/jbc.270.52.31249. [DOI] [PubMed] [Google Scholar]
  23. Clogston C. L., Boone T. C., Crandall B. C., Mendiaz E. A., Lu H. S. Disulfide structures of human interleukin-6 are similar to those of human granulocyte colony stimulating factor. Arch Biochem Biophys. 1989 Jul;272(1):144–151. doi: 10.1016/0003-9861(89)90205-1. [DOI] [PubMed] [Google Scholar]
  24. Content J., De Wit L., Pierard D., Derynck R., De Clercq E., Fiers W. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta. Proc Natl Acad Sci U S A. 1982 May;79(9):2768–2772. doi: 10.1073/pnas.79.9.2768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Contreras R., Carrez D., Kinghorn J. R., van den Hondel C. A., Fiers W. Efficient KEX2-like processing of a glucoamylase-interleukin-6 fusion protein by Aspergillus nidulans and secretion of mature interleukin-6. Biotechnology (N Y) 1991 Apr;9(4):378–381. doi: 10.1038/nbt0491-378. [DOI] [PubMed] [Google Scholar]
  26. Coulie P. G., Vanhecke A., Van Damme J., Cayphas S., Poupart P., De Wit L., Content J. High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells. Eur J Immunol. 1987 Oct;17(10):1435–1440. doi: 10.1002/eji.1830171008. [DOI] [PubMed] [Google Scholar]
  27. Cunningham B. C., Ultsch M., De Vos A. M., Mulkerrin M. G., Clauser K. R., Wells J. A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 1991 Nov 8;254(5033):821–825. doi: 10.1126/science.1948064. [DOI] [PubMed] [Google Scholar]
  28. Cunningham B. C., Wells J. A. Comparison of a structural and a functional epitope. J Mol Biol. 1993 Dec 5;234(3):554–563. doi: 10.1006/jmbi.1993.1611. [DOI] [PubMed] [Google Scholar]
  29. Czupryn M. J., McCoy J. M., Scoble H. A. Structure-function relationships in human interleukin-11. Identification of regions involved in activity by chemical modification and site-directed mutagenesis. J Biol Chem. 1995 Jan 13;270(2):978–985. doi: 10.1074/jbc.270.2.978. [DOI] [PubMed] [Google Scholar]
  30. D'Alessandro F., Colamonici O. R., Nordan R. P. Direct association of interleukin-6 with a 130-kDa component of the interleukin-6 receptor system. J Biol Chem. 1993 Jan 25;268(3):2149–2153. [PubMed] [Google Scholar]
  31. Danley D. E., Strick C. A., James L. C., Lanzetti A. J., Otterness I. G., Grenett H. E., Fuller G. M. Identification and characterization of a C-terminally extended form of recombinant murine IL-6. FEBS Lett. 1991 May 20;283(1):135–139. doi: 10.1016/0014-5793(91)80571-j. [DOI] [PubMed] [Google Scholar]
  32. Davis S., Aldrich T. H., Valenzuela D. M., Wong V. V., Furth M. E., Squinto S. P., Yancopoulos G. D. The receptor for ciliary neurotrophic factor. Science. 1991 Jul 5;253(5015):59–63. doi: 10.1126/science.1648265. [DOI] [PubMed] [Google Scholar]
  33. De Benedetti F., Massa M., Pignatti P., Albani S., Novick D., Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest. 1994 May;93(5):2114–2119. doi: 10.1172/JCI117206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. De Filippis V., de Laureto P. P., Toniutti N., Fontana A. Acid-induced molten globule state of a fully active mutant of human interleukin-6. Biochemistry. 1996 Sep 3;35(35):11503–11511. doi: 10.1021/bi9604587. [DOI] [PubMed] [Google Scholar]
  35. De Serio A., Graziani R., Laufer R., Ciliberto G., Paonessa G. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex. J Mol Biol. 1995 Dec 15;254(5):795–800. doi: 10.1006/jmbi.1995.0655. [DOI] [PubMed] [Google Scholar]
  36. Di Marco A., Gloaguen I., Graziani R., Paonessa G., Saggio I., Hudson K. R., Laufer R. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9247–9252. doi: 10.1073/pnas.93.17.9247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Dittrich E., Haft C. R., Muys L., Heinrich P. C., Graeve L. A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. J Biol Chem. 1996 Mar 8;271(10):5487–5494. doi: 10.1074/jbc.271.10.5487. [DOI] [PubMed] [Google Scholar]
  38. Dittrich E., Rose-John S., Gerhartz C., Müllberg J., Stoyan T., Yasukawa K., Heinrich P. C., Graeve L. Identification of a region within the cytoplasmic domain of the interleukin-6 (IL-6) signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptor. J Biol Chem. 1994 Jul 22;269(29):19014–19020. [PubMed] [Google Scholar]
  39. Droogmans L., Cludts I., Cleuter Y., Kettmann R., Burny A. Nucleotide sequence of bovine interleukin-6 cDNA. DNA Seq. 1992;2(6):411–413. doi: 10.3109/10425179209020821. [DOI] [PubMed] [Google Scholar]
  40. Ealick S. E., Cook W. J., Vijay-Kumar S., Carson M., Nagabhushan T. L., Trotta P. P., Bugg C. E. Three-dimensional structure of recombinant human interferon-gamma. Science. 1991 May 3;252(5006):698–702. doi: 10.1126/science.1902591. [DOI] [PubMed] [Google Scholar]
  41. Ebrahimi B., Roy D. J., Bird P., Sargan D. R. Cloning, sequencing and expression of the ovine interleukin 6 gene. Cytokine. 1995 Apr;7(3):232–236. doi: 10.1006/cyto.1995.0026. [DOI] [PubMed] [Google Scholar]
  42. Ehlers M., Grötzinger J., Fischer M., Bos H. K., Brakenhoff J. P., Rose-John S. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation. J Interferon Cytokine Res. 1996 Aug;16(8):569–576. doi: 10.1089/jir.1996.16.569. [DOI] [PubMed] [Google Scholar]
  43. Ehlers M., Grötzinger J., deHon F. D., Müllberg J., Brakenhoff J. P., Liu J., Wollmer A., Rose-John S. Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. J Immunol. 1994 Aug 15;153(4):1744–1753. [PubMed] [Google Scholar]
  44. Ehlers M., de Hon F. D., Bos H. K., Horsten U., Kurapkat G., van De Leur H. S., Grötzinger J., Wollmer A., Brakenhoff J. P., Rose-John S. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. J Biol Chem. 1995 Apr 7;270(14):8158–8163. doi: 10.1074/jbc.270.14.8158. [DOI] [PubMed] [Google Scholar]
  45. Eisenthal A., Kashtan H., Rabau M., Ramakrishna V., Chaitchik S., Skornick Y. Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells. Cancer Immunol Immunother. 1993;36(2):101–107. doi: 10.1007/BF01754409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ekida T., Nishimura C., Masuda S., Itoh S., Shimada I., Arata Y. A receptor-binding peptide from human interleukin-6: isolation and a proton nuclear magnetic resonance study. Biochem Biophys Res Commun. 1992 Nov 30;189(1):211–220. doi: 10.1016/0006-291x(92)91546-3. [DOI] [PubMed] [Google Scholar]
  47. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994 Oct 1;180(4):1243–1250. doi: 10.1084/jem.180.4.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Feng Y., Klein B. K., McWherter C. A. Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3. J Mol Biol. 1996 Jun 14;259(3):524–541. doi: 10.1006/jmbi.1996.0337. [DOI] [PubMed] [Google Scholar]
  49. Feng Y., Klein B. K., Vu L., Aykent S., McWherter C. A. 1H, 13C, and 15N NMR resonance assignments, secondary structure, and backbone topology of a variant of human interleukin-3. Biochemistry. 1995 May 16;34(19):6540–6551. doi: 10.1021/bi00019a036. [DOI] [PubMed] [Google Scholar]
  50. Fiorillo M. T., Cabibbo A., Iacopetti P., Fattori E., Ciliberto G. Analysis of human/mouse interleukin-6 hybrid proteins: both amino and carboxy termini of human interleukin-6 are required for in vitro receptor binding. Eur J Immunol. 1992 Oct;22(10):2609–2615. doi: 10.1002/eji.1830221021. [DOI] [PubMed] [Google Scholar]
  51. Fontaine V., Brakenhoff J., De Wit L., Arcone R., Ciliberto G., Content J. Internal deletions in human interleukin-6: structure-function analysis. Gene. 1991 Aug 15;104(2):227–234. doi: 10.1016/0378-1119(91)90254-9. [DOI] [PubMed] [Google Scholar]
  52. Fontaine V., Ooms J., Content J. Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: involvement of the Arg168 in the binding site. Eur J Immunol. 1994 May;24(5):1041–1045. doi: 10.1002/eji.1830240505. [DOI] [PubMed] [Google Scholar]
  53. Fontaine V., Savino R., Arcone R., de Wit L., Brakenhoff J. P., Content J., Ciliberto G. Involvement of the Arg179 in the active site of human IL-6. Eur J Biochem. 1993 Feb 1;211(3):749–755. doi: 10.1111/j.1432-1033.1993.tb17605.x. [DOI] [PubMed] [Google Scholar]
  54. Fourcin M., Chevalier S., Guillet C., Robledo O., Froger J., Pouplard-Barthelaix A., Gascan H. gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses. J Biol Chem. 1996 May 17;271(20):11756–11760. doi: 10.1074/jbc.271.20.11756. [DOI] [PubMed] [Google Scholar]
  55. Fourcin M., Chevalier S., Lebrun J. J., Kelly P., Pouplard A., Wijdenes J., Gascan H. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor. Eur J Immunol. 1994 Jan;24(1):277–280. doi: 10.1002/eji.1830240143. [DOI] [PubMed] [Google Scholar]
  56. Frieling J. T., Sauerwein R. W., Wijdenes J., Hendriks T., van der Linden C. J. Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine. 1994 Jul;6(4):376–381. doi: 10.1016/1043-4666(94)90061-2. [DOI] [PubMed] [Google Scholar]
  57. Fuh G., Cunningham B. C., Fukunaga R., Nagata S., Goeddel D. V., Wells J. A. Rational design of potent antagonists to the human growth hormone receptor. Science. 1992 Jun 19;256(5064):1677–1680. doi: 10.1126/science.256.5064.1677. [DOI] [PubMed] [Google Scholar]
  58. Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell. 1990 Apr 20;61(2):341–350. doi: 10.1016/0092-8674(90)90814-u. [DOI] [PubMed] [Google Scholar]
  59. Gaillard J. P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., Maruo N., Taga T., Kishimoto T., Klein B. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol. 1993 Apr;23(4):820–824. doi: 10.1002/eji.1830230408. [DOI] [PubMed] [Google Scholar]
  60. Gaillard J. P., Liautard J., Mani J. C., Fernandez Suarez J. M., Klein B., Brochier J. Identification of a novel antigenic structure of the human receptor for interleukin-6 involved in the interaction with the glycoprotein 130 chain. Immunology. 1996 Sep;89(1):135–141. doi: 10.1046/j.1365-2567.1996.d01-709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251–7255. doi: 10.1073/pnas.84.20.7251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  63. Gearing D. P., Thut C. J., VandeBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991 Oct;10(10):2839–2848. doi: 10.1002/j.1460-2075.1991.tb07833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Geiger T., Andus T., Bauer J., Northoff H., Ganter U., Hirano T., Kishimoto T., Heinrich P. C. Cell-free-synthesized interleukin-6 (BSF-2/IFN-beta 2) exhibits hepatocyte-stimulating activity. Eur J Biochem. 1988 Jul 15;175(1):181–186. doi: 10.1111/j.1432-1033.1988.tb14181.x. [DOI] [PubMed] [Google Scholar]
  65. Gerhartz C., Heesel B., Sasse J., Hemmann U., Landgraf C., Schneider-Mergener J., Horn F., Heinrich P. C., Graeve L. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J Biol Chem. 1996 May 31;271(22):12991–12998. doi: 10.1074/jbc.271.22.12991. [DOI] [PubMed] [Google Scholar]
  66. Goitsuka R., Ohashi T., Ono K., Yasukawa K., Koishibara Y., Fukui H., Ohsugi Y., Hasegawa A. IL-6 activity in feline infectious peritonitis. J Immunol. 1990 Apr 1;144(7):2599–2603. [PubMed] [Google Scholar]
  67. Goodwin R. G., Friend D., Ziegler S. F., Jerzy R., Falk B. A., Gimpel S., Cosman D., Dower S. K., March C. J., Namen A. E. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell. 1990 Mar 23;60(6):941–951. doi: 10.1016/0092-8674(90)90342-c. [DOI] [PubMed] [Google Scholar]
  68. Grenett H. E., Danley D. E., Strick C. A., James L. C., Otterness I. G., Fuentes N., Nesbitt J. E., Fuller G. M. Isolation and characterization of biologically active murine interleukin-6 produced in Escherichia coli. Gene. 1991 May 30;101(2):267–271. doi: 10.1016/0378-1119(91)90422-8. [DOI] [PubMed] [Google Scholar]
  69. Gross V., Andus T., Castell J., Vom Berg D., Heinrich P. C., Gerok W. O- and N-glycosylation lead to different molecular mass forms of human monocyte interleukin-6. FEBS Lett. 1989 Apr 24;247(2):323–326. doi: 10.1016/0014-5793(89)81361-4. [DOI] [PubMed] [Google Scholar]
  70. Grossman R. M., Krueger J., Yourish D., Granelli-Piperno A., Murphy D. P., May L. T., Kupper T. S., Sehgal P. B., Gottlieb A. B. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6367–6371. doi: 10.1073/pnas.86.16.6367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Guisez Y., Tison B., Vandekerckhove J., Demolder J., Bauw G., Haegeman G., Fiers W., Contreras R. Production and purification of recombinant human interleukin-6 secreted by the yeast Saccharomyces cerevisiae. Eur J Biochem. 1991 May 23;198(1):217–222. doi: 10.1111/j.1432-1033.1991.tb16004.x. [DOI] [PubMed] [Google Scholar]
  72. Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J., Fiers W. Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 1986 Sep 15;159(3):625–632. doi: 10.1111/j.1432-1033.1986.tb09931.x. [DOI] [PubMed] [Google Scholar]
  73. Hammacher A., Simpson R. J., Nice E. C. The interleukin-6 (IL-6) partial antagonist (Q159E,T162P)IL-6 interacts with the IL-6 receptor and gp130 but fails to induce a stable hexameric receptor complex. J Biol Chem. 1996 Mar 8;271(10):5464–5473. doi: 10.1074/jbc.271.10.5464. [DOI] [PubMed] [Google Scholar]
  74. Hammacher A., Ward L. D., Weinstock J., Treutlein H., Yasukawa K., Simpson R. J. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994 Dec;3(12):2280–2293. doi: 10.1002/pro.5560031213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Harlos K., Martin D. M., O'Brien D. P., Jones E. Y., Stuart D. I., Polikarpov I., Miller A., Tuddenham E. G., Boys C. W. Crystal structure of the extracellular region of human tissue factor. Nature. 1994 Aug 25;370(6491):662–666. doi: 10.1038/370662a0. [DOI] [PubMed] [Google Scholar]
  76. Harris N. L., Presnell S. R., Cohen F. E. Four helix bundle diversity in globular proteins. J Mol Biol. 1994 Mar 11;236(5):1356–1368. doi: 10.1016/0022-2836(94)90063-9. [DOI] [PubMed] [Google Scholar]
  77. Heaney M. L., Golde D. W. Soluble cytokine receptors. Blood. 1996 Feb 1;87(3):847–857. [PubMed] [Google Scholar]
  78. Heldin C. H. Dimerization of cell surface receptors in signal transduction. Cell. 1995 Jan 27;80(2):213–223. doi: 10.1016/0092-8674(95)90404-2. [DOI] [PubMed] [Google Scholar]
  79. Helfgott D. C., Tatter S. B., Santhanam U., Clarick R. H., Bhardwaj N., May L. T., Sehgal P. B. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol. 1989 Feb 1;142(3):948–953. [PubMed] [Google Scholar]
  80. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990 Dec 21;63(6):1149–1157. doi: 10.1016/0092-8674(90)90411-7. [DOI] [PubMed] [Google Scholar]
  81. Hibi M., Nakajima K., Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med (Berl) 1996 Jan;74(1):1–12. doi: 10.1007/BF00202068. [DOI] [PubMed] [Google Scholar]
  82. Hill C. P., Osslund T. D., Eisenberg D. The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5167–5171. doi: 10.1073/pnas.90.11.5167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison-Smith M., Gough N. M., Begley C. G., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994 Oct 17;13(20):4765–4775. doi: 10.1002/j.1460-2075.1994.tb06802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Hirano T., Matsuda T., Turner M., Miyasaka N., Buchan G., Tang B., Sato K., Shimizu M., Maini R., Feldmann M. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol. 1988 Nov;18(11):1797–1801. doi: 10.1002/eji.1830181122. [DOI] [PubMed] [Google Scholar]
  85. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K. H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A. 1985 Aug;82(16):5490–5494. doi: 10.1073/pnas.82.16.5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986 Nov 6;324(6092):73–76. doi: 10.1038/324073a0. [DOI] [PubMed] [Google Scholar]
  87. Hiraoka O., Anaguchi H., Asakura A., Ota Y. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor in formation of a 2:1 receptor-ligand complex. J Biol Chem. 1995 Oct 27;270(43):25928–25934. doi: 10.1074/jbc.270.43.25928. [DOI] [PubMed] [Google Scholar]
  88. Hirata Y., Taga T., Hibi M., Nakano N., Hirano T., Kishimoto T. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J Immunol. 1989 Nov 1;143(9):2900–2906. [PubMed] [Google Scholar]
  89. Hirota H., Yoshida K., Kishimoto T., Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4862–4866. doi: 10.1073/pnas.92.11.4862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Hoffman R. C., Moy F. J., Price V., Richardson J., Kaubisch D., Frieden E. A., Krakover J. D., Castner B. J., King J., March C. J. Resonance assignments for Oncostatin M, a 24-kDa alpha-helical protein. J Biomol NMR. 1996 Jun;7(4):273–282. doi: 10.1007/BF00200429. [DOI] [PubMed] [Google Scholar]
  91. Honda M., Kitamura K., Mizutani Y., Oishi M., Arai M., Okura T., Igarahi K., Yasukawa K., Hirano T., Kishimoto T. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J Immunol. 1990 Dec 15;145(12):4059–4064. [PubMed] [Google Scholar]
  92. Honda M., Yamamoto S., Cheng M., Yasukawa K., Suzuki H., Saito T., Osugi Y., Tokunaga T., Kishimoto T. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol. 1992 Apr 1;148(7):2175–2180. [PubMed] [Google Scholar]
  93. Horii Y., Muraguchi A., Iwano M., Matsuda T., Hirayama T., Yamada H., Fujii Y., Dohi K., Ishikawa H., Ohmoto Y. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989 Dec 15;143(12):3949–3955. [PubMed] [Google Scholar]
  94. Horiuchi S., Koyanagi Y., Zhou Y., Miyamoto H., Tanaka Y., Waki M., Matsumoto A., Yamamoto M., Yamamoto N. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol. 1994 Aug;24(8):1945–1948. doi: 10.1002/eji.1830240837. [DOI] [PubMed] [Google Scholar]
  95. Horsten U., Schmitz-Van de Leur H., Müllberg J., Heinrich P. C., Rose-John S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 1995 Feb 20;360(1):43–46. doi: 10.1016/0014-5793(95)00053-c. [DOI] [PubMed] [Google Scholar]
  96. Houssiau F. A., Devogelaer J. P., Van Damme J., de Deuxchaisnes C. N., Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988 Jun;31(6):784–788. doi: 10.1002/art.1780310614. [DOI] [PubMed] [Google Scholar]
  97. Ida N., Sakurai S., Hosaka T., Hosoi K., Kunitomo T., Shimazu T., Maruyama T., Matsuura Y., Kohase M. Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis. Biochem Biophys Res Commun. 1989 Dec 15;165(2):728–734. doi: 10.1016/s0006-291x(89)80027-0. [DOI] [PubMed] [Google Scholar]
  98. Ikebuchi K., Wong G. G., Clark S. C., Ihle J. N., Hirai Y., Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9035–9039. doi: 10.1073/pnas.84.24.9035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Inoue M., Nakayama C., Kikuchi K., Kimura T., Ishige Y., Ito A., Kanaoka M., Noguchi H. D1 cap region involved in the receptor recognition and neural cell survival activity of human ciliary neurotrophic factor. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8579–8583. doi: 10.1073/pnas.92.19.8579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Ip N. Y., Nye S. H., Boulton T. G., Davis S., Taga T., Li Y., Birren S. J., Yasukawa K., Kishimoto T., Anderson D. J. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell. 1992 Jun 26;69(7):1121–1132. doi: 10.1016/0092-8674(92)90634-o. [DOI] [PubMed] [Google Scholar]
  101. Jambou R. C., Snouwaert J. N., Bishop G. A., Stebbins J. R., Frelinger J. A., Fowlkes D. M. High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9426–9430. doi: 10.1073/pnas.85.24.9426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983 Dec;22(12):2577–2637. doi: 10.1002/bip.360221211. [DOI] [PubMed] [Google Scholar]
  103. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988 Mar 3;332(6159):83–85. doi: 10.1038/332083a0. [DOI] [PubMed] [Google Scholar]
  104. Kestler D. P., Agarwal S., Cobb J., Goldstein K. M., Hall R. E. Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells. Blood. 1995 Dec 15;86(12):4559–4567. [PubMed] [Google Scholar]
  105. King D. P., Schrenzel M. D., McKnight M. L., Reidarson T. H., Hanni K. D., Stott J. L., Ferrick D. A. Molecular cloning and sequencing of interleukin 6 cDNA fragments from the harbor seal (Phoca vitulina), killer whale (Orcinus orca), and Southern sea otter (Enhydra lutris nereis). Immunogenetics. 1996;43(4):190–195. doi: 10.1007/BF00587299. [DOI] [PubMed] [Google Scholar]
  106. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992 Oct 23;258(5082):593–597. doi: 10.1126/science.1411569. [DOI] [PubMed] [Google Scholar]
  107. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 1994 Jan 28;76(2):253–262. doi: 10.1016/0092-8674(94)90333-6. [DOI] [PubMed] [Google Scholar]
  108. Klein B., Brailly H. Cytokine-binding proteins: stimulating antagonists. Immunol Today. 1995 May;16(5):216–220. doi: 10.1016/0167-5699(95)80161-8. [DOI] [PubMed] [Google Scholar]
  109. Klein B., Wijdenes J., Zhang X. G., Jourdan M., Boiron J. M., Brochier J., Liautard J., Merlin M., Clement C., Morel-Fournier B. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 1991 Sep 1;78(5):1198–1204. [PubMed] [Google Scholar]
  110. Klein B., Zhang X. G., Lu Z. Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood. 1995 Feb 15;85(4):863–872. [PubMed] [Google Scholar]
  111. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994 Mar 24;368(6469):339–342. doi: 10.1038/368339a0. [DOI] [PubMed] [Google Scholar]
  112. Krakauer T., Snouwaert J. N., Fowlkes D. M., Krakauer H. Analysis of the heterogeneity of the biological responses to native and mutant human interleukin-6. J Leukoc Biol. 1992 Oct;52(4):415–420. doi: 10.1002/jlb.52.4.415. [DOI] [PubMed] [Google Scholar]
  113. Krüttgen A., Grötzinger J., Kurapkat G., Weis J., Simon R., Thier M., Schröder M., Heinrich P., Wollmer A., Comeau M. Human ciliary neurotrophic factor: a structure-function analysis. Biochem J. 1995 Jul 1;309(Pt 1):215–220. doi: 10.1042/bj3090215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Krüttgen A., Rose-John S., Dufhues G., Bender S., Lütticken C., Freyer P., Heinrich P. C. The three carboxy-terminal amino acids of human interleukin-6 are essential for its biological activity. FEBS Lett. 1990 Oct 29;273(1-2):95–98. doi: 10.1016/0014-5793(90)81059-w. [DOI] [PubMed] [Google Scholar]
  115. Krüttgen A., Rose-John S., Möller C., Wroblowski B., Wollmer A., Müllberg J., Hirano T., Kishimoto T., Heinrich P. C. Structure-function analysis of human interleukin-6. Evidence for the involvement of the carboxy-terminus in function. FEBS Lett. 1990 Mar 26;262(2):323–326. doi: 10.1016/0014-5793(90)80219-9. [DOI] [PubMed] [Google Scholar]
  116. Kukielka G. L., Youker K. A., Hawkins H. K., Perrard J. L., Michael L. H., Ballantyne C. M., Smith C. W., Entman M. L. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann N Y Acad Sci. 1994 Jun 17;723:258–270. [PubMed] [Google Scholar]
  117. Larsen A., Davis T., Curtis B. M., Gimpel S., Sims J. E., Cosman D., Park L., Sorensen E., March C. J., Smith C. A. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med. 1990 Dec 1;172(6):1559–1570. doi: 10.1084/jem.172.6.1559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Layton J. E., Morstyn G., Fabri L. J., Reid G. E., Burgess A. W., Simpson R. J., Nice E. C. Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodies. J Biol Chem. 1991 Dec 15;266(35):23815–23823. [PubMed] [Google Scholar]
  119. Layton M. J., Owczarek C. M., Metcalf D., Clark R. L., Smith D. K., Treutlein H. R., Nicola N. A. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues. J Biol Chem. 1994 Nov 25;269(47):29891–29896. [PubMed] [Google Scholar]
  120. Leebeek F. W., Fowlkes D. M. Construction and functional analysis of hybrid interleukin-6 variants. Characterization of the role of the C-terminus for species specificity. FEBS Lett. 1992 Jul 20;306(2-3):262–264. doi: 10.1016/0014-5793(92)81013-c. [DOI] [PubMed] [Google Scholar]
  121. Leebeek F. W., Kariya K., Schwabe M., Fowlkes D. M. Identification of a receptor binding site in the carboxyl terminus of human interleukin-6. J Biol Chem. 1992 Jul 25;267(21):14832–14838. [PubMed] [Google Scholar]
  122. Leutz A., Damm K., Sterneck E., Kowenz E., Ness S., Frank R., Gausepohl H., Pan Y. C., Smart J., Hayman M. Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. EMBO J. 1989 Jan;8(1):175–181. doi: 10.1002/j.1460-2075.1989.tb03362.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Levy Y., Tsapis A., Brouet J. C. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J Clin Invest. 1991 Aug;88(2):696–699. doi: 10.1172/JCI115355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Li X., Rock F., Chong P., Cockle S., Keating A., Ziltener H., Klein M. Structure-function analysis of the C-terminal segment of human interleukin-6. J Biol Chem. 1993 Oct 25;268(30):22377–22384. [PubMed] [Google Scholar]
  125. Liautard J., Gaillard J. P., Mani J. C., Montero-Julian F., Duperray C., Lu Z. Y., Jourdan M., Klein B., Brailly H., Brochier J. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies. Eur Cytokine Netw. 1994 May-Jun;5(3):293–300. [PubMed] [Google Scholar]
  126. Liu J., Modrell B., Aruffo A., Marken J. S., Taga T., Yasukawa K., Murakami M., Kishimoto T., Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem. 1992 Aug 25;267(24):16763–16766. [PubMed] [Google Scholar]
  127. Liu Y., Wei S. H., Ho A. S., de Waal Malefyt R., Moore K. W. Expression cloning and characterization of a human IL-10 receptor. J Immunol. 1994 Feb 15;152(4):1821–1829. [PubMed] [Google Scholar]
  128. Livnah O., Stura E. A., Johnson D. L., Middleton S. A., Mulcahy L. S., Wrighton N. C., Dower W. J., Jolliffe L. K., Wilson I. A. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science. 1996 Jul 26;273(5274):464–471. doi: 10.1126/science.273.5274.464. [DOI] [PubMed] [Google Scholar]
  129. Lovejoy B., Cascio D., Eisenberg D. Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). J Mol Biol. 1993 Dec 5;234(3):640–653. doi: 10.1006/jmbi.1993.1617. [DOI] [PubMed] [Google Scholar]
  130. Lowman H. B., Wells J. A. Affinity maturation of human growth hormone by monovalent phage display. J Mol Biol. 1993 Dec 5;234(3):564–578. doi: 10.1006/jmbi.1993.1612. [DOI] [PubMed] [Google Scholar]
  131. Lu Z. Y., Brochier J., Wijdenes J., Brailly H., Bataille R., Klein B. High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. Eur J Immunol. 1992 Nov;22(11):2819–2824. doi: 10.1002/eji.1830221110. [DOI] [PubMed] [Google Scholar]
  132. Matsuura Y., Tatsumi M., Enami K., Morikawa S., Yamazaki S., Kohase M. Expression of IL-6/IFN-beta 2 in a baculovirus system and its biological function. Ann N Y Acad Sci. 1989;557:122–129. doi: 10.1111/j.1749-6632.1989.tb24005.x. [DOI] [PubMed] [Google Scholar]
  133. May L. T., Ghrayeb J., Santhanam U., Tatter S. B., Sthoeger Z., Helfgott D. C., Chiorazzi N., Grieninger G., Sehgal P. B. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem. 1988 Jun 5;263(16):7760–7766. [PubMed] [Google Scholar]
  134. May L. T., Shaw J. E., Khanna A. K., Zabriskie J. B., Sehgal P. B. Marked cell-type-specific differences in glycosylation of human interleukin-6. Cytokine. 1991 May;3(3):204–211. doi: 10.1016/1043-4666(91)90018-9. [DOI] [PubMed] [Google Scholar]
  135. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 1993 Dec 15;82(12):3515–3523. [PubMed] [Google Scholar]
  136. Milburn M. V., Hassell A. M., Lambert M. H., Jordan S. R., Proudfoot A. E., Graber P., Wells T. N. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature. 1993 May 13;363(6425):172–176. doi: 10.1038/363172a0. [DOI] [PubMed] [Google Scholar]
  137. Miyajima A., Hara T., Kitamura T. Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biochem Sci. 1992 Oct;17(10):378–382. doi: 10.1016/0968-0004(92)90004-s. [DOI] [PubMed] [Google Scholar]
  138. Mock B. A., Nordan R. P., Justice M. J., Kozak C., Jenkins N. A., Copeland N. G., Clark S. C., Wong G. G., Rudikoff S. The murine Il-6 gene maps to the proximal region of chromosome 5. J Immunol. 1989 Feb 15;142(4):1372–1376. [PubMed] [Google Scholar]
  139. Morton C. J., Simpson R. J., Norton R. S. Solution structure of synthetic peptides corresponding to the C-terminal helix of interleukin-6. Eur J Biochem. 1994 Jan 15;219(1-2):97–107. doi: 10.1111/j.1432-1033.1994.tb19919.x. [DOI] [PubMed] [Google Scholar]
  140. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996 Dec 20;271(51):32635–32643. doi: 10.1074/jbc.271.51.32635. [DOI] [PubMed] [Google Scholar]
  141. Mott H. R., Baines B. S., Hall R. M., Cooke R. M., Driscoll P. C., Weir M. P., Campbell I. D. The solution structure of the F42A mutant of human interleukin 2. J Mol Biol. 1995 Apr 14;247(5):979–994. doi: 10.1006/jmbi.1994.0194. [DOI] [PubMed] [Google Scholar]
  142. Muller Y. A., Ultsch M. H., de Vos A. M. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution. J Mol Biol. 1996 Feb 16;256(1):144–159. doi: 10.1006/jmbi.1996.0073. [DOI] [PubMed] [Google Scholar]
  143. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993 Jun 18;260(5115):1808–1810. doi: 10.1126/science.8511589. [DOI] [PubMed] [Google Scholar]
  144. Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11349–11353. doi: 10.1073/pnas.88.24.11349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Müllberg J., Dittrich E., Graeve L., Gerhartz C., Yasukawa K., Taga T., Kishimoto T., Heinrich P. C., Rose-John S. Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 1993 Oct 11;332(1-2):174–178. doi: 10.1016/0014-5793(93)80507-q. [DOI] [PubMed] [Google Scholar]
  146. Müller T., Oehlenschläger F., Buehner M. Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models. J Mol Biol. 1995 Mar 24;247(2):360–372. doi: 10.1006/jmbi.1994.0144. [DOI] [PubMed] [Google Scholar]
  147. Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G. D., Taga T., Kishimoto T. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 1993 Aug 15;82(4):1120–1126. [PubMed] [Google Scholar]
  148. Neddermann P., Graziani R., Ciliberto G., Paonessa G. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130. J Biol Chem. 1996 Nov 29;271(48):30986–30991. doi: 10.1074/jbc.271.48.30986. [DOI] [PubMed] [Google Scholar]
  149. Nesbitt J. E., Fuller G. M. Dynamics of interleukin-6 internalization and degradation in rat hepatocytes. J Biol Chem. 1992 Mar 25;267(9):5739–5742. [PubMed] [Google Scholar]
  150. Nishimura C., Ekida T., Masuda S., Futatsugi K., Itoh S., Yasukawa K., Kishimoto T., Arata Y. Chemical modification and 1H-NMR studies on the receptor-binding region of human interleukin 6. Eur J Biochem. 1991 Mar 14;196(2):377–384. doi: 10.1111/j.1432-1033.1991.tb15827.x. [DOI] [PubMed] [Google Scholar]
  151. Nishimura C., Ekida T., Nomura K., Sakamoto K., Suzuki H., Yasukawa K., Kishimoto T., Arata Y. Role of leucine residues in the C-terminal region of human interleukin-6 in the biological activity. FEBS Lett. 1992 Oct 26;311(3):271–275. doi: 10.1016/0014-5793(92)81118-6. [DOI] [PubMed] [Google Scholar]
  152. Nishimura C., Futatsugi K., Yasukawa K., Kishimoto T., Arata Y. Site-specific mutagenesis of human interleukin-6 and its biological activity. FEBS Lett. 1991 Apr 9;281(1-2):167–169. doi: 10.1016/0014-5793(91)80384-f. [DOI] [PubMed] [Google Scholar]
  153. Nishimura C., Hanzawa H., Itoh S., Yasukawa K., Shimada I., Kishimoto T., Arata Y. Proton nuclear magnetic resonance study of human interleukin 6: chemical modifications and partial spectral assignments for the aromatic residues. Biochim Biophys Acta. 1990 Dec 5;1041(3):243–249. doi: 10.1016/0167-4838(90)90278-n. [DOI] [PubMed] [Google Scholar]
  154. Nordan R. P., Pumphrey J. G., Rudikoff S. Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol. 1987 Aug 1;139(3):813–817. [PubMed] [Google Scholar]
  155. Northemann W., Braciak T. A., Hattori M., Lee F., Fey G. H. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem. 1989 Sep 25;264(27):16072–16082. [PubMed] [Google Scholar]
  156. Novick D., Engelmann H., Revel M., Leitner O., Rubinstein M. Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding. Hybridoma. 1991 Feb;10(1):137–146. doi: 10.1089/hyb.1991.10.137. [DOI] [PubMed] [Google Scholar]
  157. Novick D., Engelmann H., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med. 1989 Oct 1;170(4):1409–1414. doi: 10.1084/jem.170.4.1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Ohashi T., Goitsuka R., Ono K., Hasegawa A. Feline hybridoma growth factor/interleukin-6 activity. J Leukoc Biol. 1989 Dec;46(6):501–507. doi: 10.1002/jlb.46.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Ohashi T., Matsumoto Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Molecular cloning of feline interleukin-6 cDNA. J Vet Med Sci. 1993 Dec;55(6):941–944. doi: 10.1292/jvms.55.941. [DOI] [PubMed] [Google Scholar]
  160. Orita T., Oh-eda M., Hasegawa M., Kuboniwa H., Esaki K., Ochi N. Polypeptide and carbohydrate structure of recombinant human interleukin-6 produced in Chinese hamster ovary cells. J Biochem. 1994 Feb;115(2):345–350. doi: 10.1093/oxfordjournals.jbchem.a124340. [DOI] [PubMed] [Google Scholar]
  161. Panayotatos N., Radziejewska E., Acheson A., Somogyi R., Thadani A., Hendrickson W. A., McDonald N. Q. Localization of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J Biol Chem. 1995 Jun 9;270(23):14007–14014. doi: 10.1074/jbc.270.23.14007. [DOI] [PubMed] [Google Scholar]
  162. Pandit J., Bohm A., Jancarik J., Halenbeck R., Koths K., Kim S. H. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science. 1992 Nov 20;258(5086):1358–1362. doi: 10.1126/science.1455231. [DOI] [PubMed] [Google Scholar]
  163. Paonessa G., Graziani R., De Serio A., Savino R., Ciapponi L., Lahm A., Salvati A. L., Toniatti C., Ciliberto G. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J. 1995 May 1;14(9):1942–1951. doi: 10.1002/j.1460-2075.1995.tb07186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Parry D. A., Minasian E., Leach S. J. Conformational homologies among cytokines: interleukins and colony stimulating factors. J Mol Recognit. 1988 Jun;1(3):107–110. doi: 10.1002/jmr.300010302. [DOI] [PubMed] [Google Scholar]
  165. Parry D. A., Minasian E., Leach S. J. Cytokine conformations: predictive studies. J Mol Recognit. 1991 Mar-Jun;4(2-3):63–75. doi: 10.1002/jmr.300040205. [DOI] [PubMed] [Google Scholar]
  166. Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995 May 5;270(18):10915–10922. doi: 10.1074/jbc.270.18.10915. [DOI] [PubMed] [Google Scholar]
  167. Poli G., Bressler P., Kinter A., Duh E., Timmer W. C., Rabson A., Justement J. S., Stanley S., Fauci A. S. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med. 1990 Jul 1;172(1):151–158. doi: 10.1084/jem.172.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G. A., Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994 Mar 1;13(5):1189–1196. doi: 10.1002/j.1460-2075.1994.tb06368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Powers R., Garrett D. S., March C. J., Frieden E. A., Gronenborn A. M., Clore G. M. The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry. 1993 Jul 6;32(26):6744–6762. doi: 10.1021/bi00077a030. [DOI] [PubMed] [Google Scholar]
  170. Powers R., Garrett D. S., March C. J., Frieden E. A., Gronenborn A. M., Clore G. M. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. Science. 1992 Jun 19;256(5064):1673–1677. doi: 10.1126/science.256.5064.1673. [DOI] [PubMed] [Google Scholar]
  171. Presnell S. R., Cohen F. E. Topological distribution of four-alpha-helix bundles. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6592–6596. doi: 10.1073/pnas.86.17.6592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Proudfoot A. E., Brown S. C., Bernard A. R., Bonnefoy J. Y., Kawashima E. H. Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal. J Protein Chem. 1993 Aug;12(4):489–497. doi: 10.1007/BF01025050. [DOI] [PubMed] [Google Scholar]
  173. Radhakrishnan R., Walter L. J., Hruza A., Reichert P., Trotta P. P., Nagabhushan T. L., Walter M. R. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure. 1996 Dec 15;4(12):1453–1463. doi: 10.1016/s0969-2126(96)00152-9. [DOI] [PubMed] [Google Scholar]
  174. Ramsay A. J., Husband A. J., Ramshaw I. A., Bao S., Matthaei K. I., Koehler G., Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science. 1994 Apr 22;264(5158):561–563. doi: 10.1126/science.8160012. [DOI] [PubMed] [Google Scholar]
  175. Reidhaar-Olson J. F., De Souza-Hart J. A., Selick H. E. Identification of residues critical to the activity of human granulocyte colony-stimulating factor. Biochemistry. 1996 Jul 16;35(28):9034–9041. doi: 10.1021/bi952705x. [DOI] [PubMed] [Google Scholar]
  176. Renauld J. C., Druez C., Kermouni A., Houssiau F., Uyttenhove C., Van Roost E., Van Snick J. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5690–5694. doi: 10.1073/pnas.89.12.5690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Richards C. D., Saklatvala J. Molecular cloning and sequence of porcine interleukin 6 cDNA and expression of mRNA in synovial fibroblasts in vitro. Cytokine. 1991 Jul;3(4):269–276. doi: 10.1016/1043-4666(91)90494-x. [DOI] [PubMed] [Google Scholar]
  178. Rock F. L., Li X., Chong P., Ida N., Klein M. Roles of disulfide bonds in recombinant human interleukin 6 conformation. Biochemistry. 1994 May 3;33(17):5146–5154. doi: 10.1021/bi00183a018. [DOI] [PubMed] [Google Scholar]
  179. Rose-John S., Heinrich P. C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J. 1994 Jun 1;300(Pt 2):281–290. doi: 10.1042/bj3000281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Rozwarski D. A., Diederichs K., Hecht R., Boone T., Karplus P. A. Refined crystal structure and mutagenesis of human granulocyte-macrophage colony-stimulating factor. Proteins. 1996 Nov;26(3):304–313. doi: 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  181. Rozwarski D. A., Gronenborn A. M., Clore G. M., Bazan J. F., Bohm A., Wlodawer A., Hatada M., Karplus P. A. Structural comparisons among the short-chain helical cytokines. Structure. 1994 Mar 15;2(3):159–173. doi: 10.1016/s0969-2126(00)00018-6. [DOI] [PubMed] [Google Scholar]
  182. Saggio I., Gloaguen I., Poiana G., Laufer R. CNTF variants with increased biological potency and receptor selectivity define a functional site of receptor interaction. EMBO J. 1995 Jul 3;14(13):3045–3054. doi: 10.1002/j.1460-2075.1995.tb07307.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Saito M., Yoshida K., Hibi M., Taga T., Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol. 1992 Jun 15;148(12):4066–4071. [PubMed] [Google Scholar]
  184. Saito T., Taga T., Miki D., Futatsugi K., Yawata H., Kishimoto T., Yasukawa K. Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functions. J Immunol Methods. 1993 Aug 9;163(2):217–223. doi: 10.1016/0022-1759(93)90125-q. [DOI] [PubMed] [Google Scholar]
  185. Salvati A. L., Lahm A., Paonessa G., Ciliberto G., Toniatti C. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. J Biol Chem. 1995 May 19;270(20):12242–12249. doi: 10.1074/jbc.270.20.12242. [DOI] [PubMed] [Google Scholar]
  186. Samudzi C. T., Burton L. E., Rubin J. R. Crystal structure of recombinant rabbit interferon-gamma at 2.7-A resolution. J Biol Chem. 1991 Nov 15;266(32):21791–21797. [PubMed] [Google Scholar]
  187. Samudzi C. T., Rubin J. R. Structure of recombinant bovine interferon-gamma at 3.0 A resolution. Acta Crystallogr D Biol Crystallogr. 1993 Nov 1;49(Pt 6):513–521. doi: 10.1107/S0907444993006924. [DOI] [PubMed] [Google Scholar]
  188. Savino R., Lahm A., Salvati A. L., Ciapponi L., Sporeno E., Altamura S., Paonessa G., Toniatti C., Ciliberto G. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 1994 Mar 15;13(6):1357–1367. doi: 10.1002/j.1460-2075.1994.tb06389.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Sehgal P. B., Zilberstein A., Ruggieri R. M., May L. T., Ferguson-Smith A., Slate D. L., Revel M., Ruddle F. H. Human chromosome 7 carries the beta 2 interferon gene. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5219–5222. doi: 10.1073/pnas.83.14.5219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Senda T., Saitoh S., Mitsui Y. Refined crystal structure of recombinant murine interferon-beta at 2.15 A resolution. J Mol Biol. 1995 Oct 13;253(1):187–207. doi: 10.1006/jmbi.1995.0544. [DOI] [PubMed] [Google Scholar]
  191. Shimamura T., Taki S., Honda H., Yokota M., Ito S., Takahara Y. Analysis of interleukin 6 (IL-6)/IL-6 receptor system using monoclonal anti-IL-6 antibodies. Mol Immunol. 1991 Nov;28(11):1155–1161. doi: 10.1016/0161-5890(91)90001-z. [DOI] [PubMed] [Google Scholar]
  192. Snouwaert J. N., Leebeek F. W., Fowlkes D. M. Role of disulfide bonds in biologic activity of human interleukin-6. J Biol Chem. 1991 Dec 5;266(34):23097–23102. [PubMed] [Google Scholar]
  193. Snyers L., Fontaine V., Content J. Modulation of interleukin-6 receptors in human cells. Ann N Y Acad Sci. 1989;557:388–395. doi: 10.1111/j.1749-6632.1989.tb24031.x. [DOI] [PubMed] [Google Scholar]
  194. Somers W., Stahl M., Seehra J. S. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997 Mar 3;16(5):989–997. doi: 10.1093/emboj/16.5.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Somers W., Stahl M., Seehra J. S. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997 Mar 3;16(5):989–997. doi: 10.1093/emboj/16.5.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Somers W., Ultsch M., De Vos A. M., Kossiakoff A. A. The X-ray structure of a growth hormone-prolactin receptor complex. Nature. 1994 Dec 1;372(6505):478–481. doi: 10.1038/372478a0. [DOI] [PubMed] [Google Scholar]
  197. Sporeno E., Paonessa G., Salvati A. L., Graziani R., Delmastro P., Ciliberto G., Toniatti C. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. J Biol Chem. 1994 Apr 15;269(15):10991–10995. [PubMed] [Google Scholar]
  198. Stahl N., Boulton T. G., Farruggella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 1994 Jan 7;263(5143):92–95. doi: 10.1126/science.8272873. [DOI] [PubMed] [Google Scholar]
  199. Stahl N., Farruggella T. J., Boulton T. G., Zhong Z., Darnell J. E., Jr, Yancopoulos G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 1995 Mar 3;267(5202):1349–1353. doi: 10.1126/science.7871433. [DOI] [PubMed] [Google Scholar]
  200. Stoyan T., Michaelis U., Schooltink H., Van Dam M., Rudolph R., Heinrich P. C., Rose-John S. Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur J Biochem. 1993 Aug 15;216(1):239–245. doi: 10.1111/j.1432-1033.1993.tb18138.x. [DOI] [PubMed] [Google Scholar]
  201. Sugita T., Totsuka T., Saito M., Yamasaki K., Taga T., Hirano T., Kishimoto T. Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis. J Exp Med. 1990 Jun 1;171(6):2001–2009. doi: 10.1084/jem.171.6.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Sundström M., Lundqvist T., Rödin J., Giebel L. B., Milligan D., Norstedt G. Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 A resolution. J Biol Chem. 1996 Dec 13;271(50):32197–32203. doi: 10.1074/jbc.271.50.32197. [DOI] [PubMed] [Google Scholar]
  203. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989 Aug 11;58(3):573–581. doi: 10.1016/0092-8674(89)90438-8. [DOI] [PubMed] [Google Scholar]
  204. Taga T., Kawanishi Y., Hardy R. R., Hirano T., Kishimoto T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med. 1987 Oct 1;166(4):967–981. doi: 10.1084/jem.166.4.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopoulos G. D., Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10998–11001. doi: 10.1073/pnas.89.22.10998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Takai Y., Wong G. G., Clark S. C., Burakoff S. J., Herrmann S. H. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol. 1988 Jan 15;140(2):508–512. [PubMed] [Google Scholar]
  207. Tanabe O., Akira S., Kamiya T., Wong G. G., Hirano T., Kishimoto T. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J Immunol. 1988 Dec 1;141(11):3875–3881. [PubMed] [Google Scholar]
  208. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 1995 Apr 14;268(5208):251–255. doi: 10.1126/science.7716517. [DOI] [PubMed] [Google Scholar]
  209. Tartaglia L. A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G. J., Campfield L. A., Clark F. T., Deeds J. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995 Dec 29;83(7):1263–1271. doi: 10.1016/0092-8674(95)90151-5. [DOI] [PubMed] [Google Scholar]
  210. Thier M., Simon R., Krüttgen A., Rose-John S., Heinrich P. C., Schröder J. M., Weis J. Site-directed mutagenesis of human CNTF: functional analysis of recombinant variants. J Neurosci Res. 1995 Apr 15;40(6):826–835. doi: 10.1002/jnr.490400614. [DOI] [PubMed] [Google Scholar]
  211. Thoreau E., Petridou B., Kelly P. A., Djiane J., Mornon J. P. Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Lett. 1991 Apr 22;282(1):26–31. doi: 10.1016/0014-5793(91)80437-8. [DOI] [PubMed] [Google Scholar]
  212. Toniatti C., Cabibbo A., Sporena E., Salvati A. L., Cerretani M., Serafini S., Lahm A., Cortese R., Ciliberto G. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity. EMBO J. 1996 Jun 3;15(11):2726–2737. [PMC free article] [PubMed] [Google Scholar]
  213. Trowbridge I. S., Collawn J. F., Hopkins C. R. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol. 1993;9:129–161. doi: 10.1146/annurev.cb.09.110193.001021. [DOI] [PubMed] [Google Scholar]
  214. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  215. Ultsch M. H., Somers W., Kossiakoff A. A., de Vos A. M. The crystal structure of affinity-matured human growth hormone at 2 A resolution. J Mol Biol. 1994 Feb 11;236(1):286–299. doi: 10.1006/jmbi.1994.1135. [DOI] [PubMed] [Google Scholar]
  216. Van Damme J., Van Beeumen J., Decock B., Van Snick J., De Ley M., Billiau A. Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6. J Immunol. 1988 Mar 1;140(5):1534–1541. [PubMed] [Google Scholar]
  217. Van Snick J., Cayphas S., Szikora J. P., Renauld J. C., Van Roost E., Boon T., Simpson R. J. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol. 1988 Feb;18(2):193–197. doi: 10.1002/eji.1830180202. [DOI] [PubMed] [Google Scholar]
  218. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P. G., Rubira M. R., Simpson R. J. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679–9683. doi: 10.1073/pnas.83.24.9679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Van Snick J., Vink A., Cayphas S., Uyttenhove C. Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas. J Exp Med. 1987 Mar 1;165(3):641–649. doi: 10.1084/jem.165.3.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Vaughn D. E., Bjorkman P. J. The (Greek) key to structures of neural adhesion molecules. Neuron. 1996 Feb;16(2):261–273. doi: 10.1016/s0896-6273(00)80045-8. [DOI] [PubMed] [Google Scholar]
  221. Vigon I., Mornon J. P., Cocault L., Mitjavila M. T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5640–5644. doi: 10.1073/pnas.89.12.5640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Villinger F., Brar S. S., Mayne A., Chikkala N., Ansari A. A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol. 1995 Oct 15;155(8):3946–3954. [PubMed] [Google Scholar]
  223. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Walter M. R., Nagabhushan T. L. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry. 1995 Sep 26;34(38):12118–12125. doi: 10.1021/bi00038a004. [DOI] [PubMed] [Google Scholar]
  225. Walter M. R., Windsor W. T., Nagabhushan T. L., Lundell D. J., Lunn C. A., Zauodny P. J., Narula S. K. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature. 1995 Jul 20;376(6537):230–235. doi: 10.1038/376230a0. [DOI] [PubMed] [Google Scholar]
  226. Wang Y., Fuller G. M. Biosynthetic and glycosylation events of the IL-6 receptor beta-subunit, gp130. J Cell Biochem. 1995 Apr;57(4):610–618. doi: 10.1002/jcb.240570405. [DOI] [PubMed] [Google Scholar]
  227. Wang Y., Nesbitt J. E., Fuentes N. L., Fuller G. M. Molecular cloning and characterization of the rat liver IL-6 signal transducing molecule, gp130. Genomics. 1992 Nov;14(3):666–672. doi: 10.1016/s0888-7543(05)80166-1. [DOI] [PubMed] [Google Scholar]
  228. Ward L. D., Hammacher A., Howlett G. J., Matthews J. M., Fabri L., Moritz R. L., Nice E. C., Weinstock J., Simpson R. J. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex. J Biol Chem. 1996 Aug 16;271(33):20138–20144. doi: 10.1074/jbc.271.33.20138. [DOI] [PubMed] [Google Scholar]
  229. Ward L. D., Hammacher A., Zhang J. G., Weinstock J., Yasukawa K., Morton C. J., Norton R. S., Simpson R. J. Role of the C-terminus in the activity, conformation, and stability of interleukin-6. Protein Sci. 1993 Sep;2(9):1472–1481. doi: 10.1002/pro.5560020911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Ward L. D., Zhang J. G., Checkley G., Preston B., Simpson R. J. Effect of pH and denaturants on the folding and stability of murine interleukin-6. Protein Sci. 1993 Aug;2(8):1291–1300. doi: 10.1002/pro.5560020812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Ware C. B., Horowitz M. C., Renshaw B. R., Hunt J. S., Liggitt D., Koblar S. A., Gliniak B. C., McKenna H. J., Papayannopoulou T., Thoma B. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 1995 May;121(5):1283–1299. doi: 10.1242/dev.121.5.1283. [DOI] [PubMed] [Google Scholar]
  232. Weissenbach J., Chernajovsky Y., Zeevi M., Shulman L., Soreq H., Nir U., Wallach D., Perricaudet M., Tiollais P., Revel M. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7152–7156. doi: 10.1073/pnas.77.12.7152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Wells J. A. Binding in the growth hormone receptor complex. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):1–6. doi: 10.1073/pnas.93.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Wells J. A., de Vos A. M. Hematopoietic receptor complexes. Annu Rev Biochem. 1996;65:609–634. doi: 10.1146/annurev.bi.65.070196.003141. [DOI] [PubMed] [Google Scholar]
  235. Wijdenes J., Heinrich P. C., Müller-Newen G., Roche C., Gu Z. J., Clément C., Klein B. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur J Immunol. 1995 Dec;25(12):3474–3481. doi: 10.1002/eji.1830251240. [DOI] [PubMed] [Google Scholar]
  236. Wlodawer A., Pavlovsky A., Gustchina A. Hematopoietic cytokines: similarities and differences in the structures, with implications for receptor binding. Protein Sci. 1993 Sep;2(9):1373–1382. doi: 10.1002/pro.5560020902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R. M. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol. 1991 May 1;146(9):3074–3081. [PubMed] [Google Scholar]
  238. Xu G. Y., Hong J., McDonagh T., Stahl M., Kay L. E., Seehra J., Cumming D. A. Complete 1H, 15N and 13C assignments, secondary structure, and topology of recombinant human interleukin-6. J Biomol NMR. 1996 Sep;8(2):123–135. doi: 10.1007/BF00211159. [DOI] [PubMed] [Google Scholar]
  239. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science. 1988 Aug 12;241(4867):825–828. doi: 10.1126/science.3136546. [DOI] [PubMed] [Google Scholar]
  240. Yasueda H., Miyasaka Y., Shimamura T., Matsui H. Effect of semi-random mutagenesis at the C-terminal 4 amino acids of human interleukin-6 on its biological activity. Biochem Biophys Res Commun. 1992 Aug 31;187(1):18–25. doi: 10.1016/s0006-291x(05)81452-4. [DOI] [PubMed] [Google Scholar]
  241. Yasueda H., Nagase K., Hosoda A., Akiyama Y., Yamada K. High-level direct expression of semi-synthetic human interleukin-6 in Escherichia coli and production of N-terminus met-free product. Biotechnology (N Y) 1990 Nov;8(11):1036–1040. doi: 10.1038/nbt1190-1036. [DOI] [PubMed] [Google Scholar]
  242. Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki M., Suzuki H., Taga T., Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol Lett. 1992 Feb;31(2):123–130. doi: 10.1016/0165-2478(92)90138-e. [DOI] [PubMed] [Google Scholar]
  243. Yasukawa K., Hirano T., Watanabe Y., Muratani K., Matsuda T., Nakai S., Kishimoto T. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 1987 Oct;6(10):2939–2945. doi: 10.1002/j.1460-2075.1987.tb02598.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Yasukawa K., Saito T., Fukunaga T., Sekimori Y., Koishihara Y., Fukui H., Ohsugi Y., Matsuda T., Yawata H., Hirano T. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J Biochem. 1990 Oct;108(4):673–676. doi: 10.1093/oxfordjournals.jbchem.a123261. [DOI] [PubMed] [Google Scholar]
  245. Yawata H., Yasukawa K., Natsuka S., Murakami M., Yamasaki K., Hibi M., Taga T., Kishimoto T. Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J. 1993 Apr;12(4):1705–1712. doi: 10.1002/j.1460-2075.1993.tb05815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Yin T., Taga T., Tsang M. L., Yasukawa K., Kishimoto T., Yang Y. C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol. 1993 Sep 1;151(5):2555–2561. [PubMed] [Google Scholar]
  247. Yin T., Yang Y. C. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J Biol Chem. 1994 Feb 4;269(5):3731–3738. [PubMed] [Google Scholar]
  248. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):407–411. doi: 10.1073/pnas.93.1.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., Nakahata T., Kawai H., Tagoh H., Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989 Sep;74(4):1360–1367. [PubMed] [Google Scholar]
  250. Zhang J. G., Moritz R. L., Reid G. E., Ward L. D., Simpson R. J. Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms. Eur J Biochem. 1992 Aug 1;207(3):903–913. doi: 10.1111/j.1432-1033.1992.tb17123.x. [DOI] [PubMed] [Google Scholar]
  251. Zilberstein A., Ruggieri R., Korn J. H., Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986 Oct;5(10):2529–2537. doi: 10.1002/j.1460-2075.1986.tb04531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Zohlnhöfer D., Graeve L., Rose-John S., Schooltink H., Dittrich E., Heinrich P. C. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett. 1992 Jul 20;306(2-3):219–222. doi: 10.1016/0014-5793(92)81004-6. [DOI] [PubMed] [Google Scholar]
  253. de Hon F. D., Ehlers M., Rose-John S., Ebeling S. B., Bos H. K., Aarden L. A., Brakenhoff J. P. Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J Exp Med. 1994 Dec 1;180(6):2395–2400. doi: 10.1084/jem.180.6.2395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. de Hon F. D., Klaasse Bos H. K., Ebeling S. B., Grötzinger J., Kurapkat G., Rose-John S., Aarden L. A., Brakenhoff J. P. Leucine-58 in the putative 5th helical region of human interleukin (IL)-6 is important for activation of the IL-6 signal transducer, gp130. FEBS Lett. 1995 Aug 7;369(2-3):187–191. doi: 10.1016/0014-5793(95)00741-q. [DOI] [PubMed] [Google Scholar]
  255. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992 Jan 17;255(5042):306–312. doi: 10.1126/science.1549776. [DOI] [PubMed] [Google Scholar]
  256. van Dam M., Müllberg J., Schooltink H., Stoyan T., Brakenhoff J. P., Graeve L., Heinrich P. C., Rose-John S. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J Biol Chem. 1993 Jul 15;268(20):15285–15290. [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES